Venkata Rao Vantaku, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Bladder Neoplasms | 8 | 2019 | 2254 | 1.320 |
Why?
|
Aldehyde Oxidase | 1 | 2019 | 4 | 0.680 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2019 | 82 | 0.640 |
Why?
|
Metabolomics | 7 | 2019 | 1675 | 0.640 |
Why?
|
CpG Islands | 1 | 2019 | 1211 | 0.480 |
Why?
|
Fatty Acids | 2 | 2019 | 1818 | 0.450 |
Why?
|
Urinary Bladder | 1 | 2019 | 1160 | 0.420 |
Why?
|
Epithelium, Corneal | 1 | 2015 | 254 | 0.420 |
Why?
|
DNA Methylation | 2 | 2019 | 4425 | 0.300 |
Why?
|
Glycoproteins | 1 | 2015 | 2207 | 0.300 |
Why?
|
Lipopolysaccharides | 1 | 2015 | 2216 | 0.300 |
Why?
|
Chromatography, Liquid | 3 | 2019 | 998 | 0.270 |
Why?
|
Epithelial Cells | 1 | 2015 | 3697 | 0.220 |
Why?
|
Genetic Fitness | 1 | 2024 | 120 | 0.210 |
Why?
|
DNA, Mitochondrial | 2 | 2024 | 871 | 0.190 |
Why?
|
S-Adenosylhomocysteine | 1 | 2019 | 40 | 0.170 |
Why?
|
Glucuronic Acid | 1 | 2019 | 150 | 0.170 |
Why?
|
Selection, Genetic | 1 | 2024 | 874 | 0.160 |
Why?
|
Pentose Phosphate Pathway | 1 | 2019 | 126 | 0.160 |
Why?
|
Kynurenine | 1 | 2019 | 142 | 0.160 |
Why?
|
NADP | 1 | 2019 | 230 | 0.150 |
Why?
|
S-Adenosylmethionine | 1 | 2019 | 220 | 0.150 |
Why?
|
Tissue Array Analysis | 1 | 2019 | 551 | 0.140 |
Why?
|
Epigenesis, Genetic | 3 | 2019 | 3832 | 0.140 |
Why?
|
Metabolome | 3 | 2019 | 1009 | 0.140 |
Why?
|
Tryptophan | 1 | 2019 | 483 | 0.140 |
Why?
|
Gene Knockdown Techniques | 2 | 2019 | 1609 | 0.140 |
Why?
|
Nucleotides | 1 | 2019 | 455 | 0.140 |
Why?
|
Mutagens | 1 | 2017 | 181 | 0.140 |
Why?
|
Cell Division | 1 | 2024 | 4479 | 0.130 |
Why?
|
Liver Neoplasms | 2 | 2023 | 4362 | 0.120 |
Why?
|
Carcinogens | 1 | 2017 | 455 | 0.120 |
Why?
|
Cell Lineage | 1 | 2024 | 2575 | 0.120 |
Why?
|
Mass Spectrometry | 2 | 2019 | 2204 | 0.120 |
Why?
|
Metabolic Networks and Pathways | 1 | 2019 | 797 | 0.110 |
Why?
|
Neoplasm Invasiveness | 2 | 2019 | 3637 | 0.110 |
Why?
|
Moths | 1 | 2013 | 82 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2019 | 8636 | 0.110 |
Why?
|
Phospholipids | 1 | 2017 | 783 | 0.110 |
Why?
|
Tandem Mass Spectrometry | 1 | 2019 | 1197 | 0.110 |
Why?
|
Cyclooxygenase 2 | 1 | 2015 | 599 | 0.110 |
Why?
|
Aminopeptidases | 1 | 2013 | 113 | 0.110 |
Why?
|
Keratitis | 1 | 2015 | 241 | 0.100 |
Why?
|
Amino Acids | 1 | 2019 | 1713 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2531 | 0.100 |
Why?
|
Dry Eye Syndromes | 1 | 2015 | 388 | 0.090 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3619 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2331 | 0.090 |
Why?
|
Cell Death | 1 | 2015 | 1684 | 0.090 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2017 | 798 | 0.090 |
Why?
|
Central Nervous System Neoplasms | 1 | 2018 | 928 | 0.080 |
Why?
|
Thyroid Neoplasms | 1 | 2023 | 2360 | 0.080 |
Why?
|
Survival Analysis | 2 | 2019 | 10127 | 0.080 |
Why?
|
Triglycerides | 1 | 2017 | 2465 | 0.080 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5803 | 0.080 |
Why?
|
Lipids | 1 | 2019 | 3346 | 0.070 |
Why?
|
DNA Damage | 1 | 2017 | 2461 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11249 | 0.070 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 17149 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12875 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2019 | 22286 | 0.060 |
Why?
|
Lipid Peroxides | 1 | 2023 | 74 | 0.050 |
Why?
|
Oxyphil Cells | 1 | 2023 | 56 | 0.050 |
Why?
|
Fermentation | 1 | 2023 | 142 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15459 | 0.050 |
Why?
|
Disease Progression | 1 | 2019 | 13643 | 0.050 |
Why?
|
Humans | 12 | 2024 | 768369 | 0.050 |
Why?
|
Smoking | 1 | 2017 | 9099 | 0.040 |
Why?
|
Serum Albumin | 1 | 2023 | 676 | 0.040 |
Why?
|
Mice | 3 | 2024 | 82051 | 0.040 |
Why?
|
Lipid Metabolism | 2 | 2019 | 1898 | 0.040 |
Why?
|
Benzo(a)pyrene | 1 | 2017 | 28 | 0.040 |
Why?
|
Butanones | 1 | 2017 | 23 | 0.040 |
Why?
|
Nitrogenous Group Transferases | 1 | 2017 | 4 | 0.040 |
Why?
|
Oncogenes | 1 | 2023 | 1235 | 0.040 |
Why?
|
Nitrosamines | 1 | 2017 | 88 | 0.040 |
Why?
|
DNA Adducts | 1 | 2017 | 95 | 0.030 |
Why?
|
Phosphatidylethanolamines | 1 | 2017 | 131 | 0.030 |
Why?
|
Diglycerides | 1 | 2017 | 176 | 0.030 |
Why?
|
Phosphorylcholine | 1 | 2017 | 153 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2023 | 1172 | 0.030 |
Why?
|
Animals | 4 | 2024 | 169424 | 0.030 |
Why?
|
Phosphatidylserines | 1 | 2017 | 186 | 0.030 |
Why?
|
Azacitidine | 1 | 2017 | 336 | 0.030 |
Why?
|
Male | 5 | 2019 | 364761 | 0.030 |
Why?
|
Lysophospholipids | 1 | 2017 | 338 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2884 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 949 | 0.030 |
Why?
|
Hemolysin Proteins | 1 | 2013 | 113 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2072 | 0.030 |
Why?
|
Mutation | 3 | 2024 | 30235 | 0.030 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 955 | 0.020 |
Why?
|
Female | 6 | 2024 | 396926 | 0.020 |
Why?
|
Endotoxins | 1 | 2013 | 520 | 0.020 |
Why?
|
Mitochondria | 1 | 2024 | 3672 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3623 | 0.020 |
Why?
|
Cell Line | 1 | 2024 | 15610 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2013 | 617 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2013 | 2184 | 0.020 |
Why?
|
Gene Silencing | 1 | 2013 | 1502 | 0.020 |
Why?
|
Protein Conformation | 1 | 2013 | 3972 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2017 | 3472 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4077 | 0.020 |
Why?
|
Computational Biology | 1 | 2017 | 3549 | 0.020 |
Why?
|
Binding Sites | 1 | 2013 | 6029 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3436 | 0.010 |
Why?
|
Models, Molecular | 1 | 2013 | 5441 | 0.010 |
Why?
|
Glioma | 1 | 2018 | 3523 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3230 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13447 | 0.010 |
Why?
|
Protein Binding | 1 | 2013 | 9376 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17637 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2013 | 3861 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7602 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 40271 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 24310 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11928 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41782 | 0.010 |
Why?
|
Middle Aged | 2 | 2019 | 223406 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2018 | 13589 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 60038 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21157 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36840 | 0.010 |
Why?
|
Aged | 1 | 2018 | 171514 | 0.000 |
Why?
|
Adult | 1 | 2018 | 223528 | 0.000 |
Why?
|